i-SENS, Inc. (KOSDAQ:099190)
19,890
-160 (-0.80%)
Apr 10, 2026, 3:30 PM KST
i-SENS Revenue
In the year 2025, i-SENS had annual revenue of 315.44B KRW with 8.35% growth. i-SENS had revenue of 83.66B in the quarter ending December 31, 2025, with 2.88% growth.
Revenue
315.44B
Revenue Growth
+8.35%
P/S Ratio
1.81
Revenue / Employee
355.63M
Employees
887
Market Cap
569.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 315.44B | 24.31B | 8.35% |
| Dec 31, 2024 | 291.14B | 26.02B | 9.81% |
| Dec 31, 2023 | 265.12B | 283.13M | 0.11% |
| Dec 31, 2022 | 264.84B | 31.90B | 13.70% |
| Dec 31, 2021 | 232.93B | 29.23B | 14.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Seegene | 474.23B |
| InBody Co.,Ltd | 233.95B |
| WON TECH | 156.84B |
| Osang Healthcare Co.,Ltd | 128.63B |
| DRTECH | 116.30B |
| Bio Plus | 90.90B |
| L&C BIO Co.,LTD | 85.48B |
| Curexo | 74.53B |